Theravance Biopharma Stock
Your prediction
Theravance Biopharma Stock
A loss of -1.150% shows a downward development for Theravance Biopharma.
Pros and Cons of Theravance Biopharma in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Theravance Biopharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma | -1.150% | 6.410% | 11.409% | 100.000% | 5.732% | 59.615% | 17.730% |
| Rockwell Medical Inc. | -2.130% | 6.857% | 5.451% | -57.457% | 24.390% | -49.911% | -92.573% |
| Pacira Pharmaceuticals | -0.540% | -9.722% | -8.879% | -4.412% | -9.722% | -42.647% | -66.949% |
| Twist Bioscience Corp | 0.720% | 9.442% | 31.032% | -18.939% | 24.022% | 44.157% | -75.151% |
News
Here's Why Shares in Theravance Biopharma Exploded Today
Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue